Cargando…

A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science

BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Ling, Gao, Rui-Xue, Zhang, Qinhong, Li, Ang, Cai, Li-Na, Zhao, Wei-Wei, Gao, Sheng-Lan, Wang, Yang, Yue, Jinhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388009/
https://www.ncbi.nlm.nih.gov/pubmed/35984119
http://dx.doi.org/10.1097/MD.0000000000030079
_version_ 1784770128260366336
author Li, Xiao-Ling
Gao, Rui-Xue
Zhang, Qinhong
Li, Ang
Cai, Li-Na
Zhao, Wei-Wei
Gao, Sheng-Lan
Wang, Yang
Yue, Jinhuan
author_facet Li, Xiao-Ling
Gao, Rui-Xue
Zhang, Qinhong
Li, Ang
Cai, Li-Na
Zhao, Wei-Wei
Gao, Sheng-Lan
Wang, Yang
Yue, Jinhuan
author_sort Li, Xiao-Ling
collection PubMed
description BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to 2022 was analyzed using the Web of Science core collection database. We utilized CiteSpace software (6.1R2) for bibliometric analyses of countries/institutions/authors, keywords, keyword bursts, references, and their clusters. RESULTS: A total of 339 studies were identified with a continually increasing annual trend. The most productive country and collaboration was the United States. The top research hotspot is PD cognitive disorder. NMBM and artificial intelligence medical imaging have been applied in the clinical diagnosis, differential diagnosis, treatment, and prognosis of PD. The trends in this field include research on T1 weighted structure magnetic resonance imaging in accordance with voxel-based morphometry, PD cognitive disorder, and neuroimaging features of Lewy body dementia and Alzheimer disease. CONCLUSION: The development of NMBM in PD will be effectively promoted by drawing on international research hotspots and cutting-edge technologies, emphasizing international collaboration and institutional cooperation at the national level, and strengthening interdisciplinary research.
format Online
Article
Text
id pubmed-9388009
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93880092022-08-23 A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science Li, Xiao-Ling Gao, Rui-Xue Zhang, Qinhong Li, Ang Cai, Li-Na Zhao, Wei-Wei Gao, Sheng-Lan Wang, Yang Yue, Jinhuan Medicine (Baltimore) Research Article BACKGROUND: This study aimed to analyze and summarize the research hotspots and trends in neuroimaging biomarkers (NMBM) in Parkinson disease (PD) based on the Web of Science core collection database and provide new references for future studies. METHODS: Literature regarding NMBM in PD from 1998 to 2022 was analyzed using the Web of Science core collection database. We utilized CiteSpace software (6.1R2) for bibliometric analyses of countries/institutions/authors, keywords, keyword bursts, references, and their clusters. RESULTS: A total of 339 studies were identified with a continually increasing annual trend. The most productive country and collaboration was the United States. The top research hotspot is PD cognitive disorder. NMBM and artificial intelligence medical imaging have been applied in the clinical diagnosis, differential diagnosis, treatment, and prognosis of PD. The trends in this field include research on T1 weighted structure magnetic resonance imaging in accordance with voxel-based morphometry, PD cognitive disorder, and neuroimaging features of Lewy body dementia and Alzheimer disease. CONCLUSION: The development of NMBM in PD will be effectively promoted by drawing on international research hotspots and cutting-edge technologies, emphasizing international collaboration and institutional cooperation at the national level, and strengthening interdisciplinary research. Lippincott Williams & Wilkins 2022-08-19 /pmc/articles/PMC9388009/ /pubmed/35984119 http://dx.doi.org/10.1097/MD.0000000000030079 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.
spellingShingle Research Article
Li, Xiao-Ling
Gao, Rui-Xue
Zhang, Qinhong
Li, Ang
Cai, Li-Na
Zhao, Wei-Wei
Gao, Sheng-Lan
Wang, Yang
Yue, Jinhuan
A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title_full A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title_fullStr A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title_full_unstemmed A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title_short A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
title_sort bibliometric analysis of neuroimaging biomarkers in parkinson disease based on web of science
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388009/
https://www.ncbi.nlm.nih.gov/pubmed/35984119
http://dx.doi.org/10.1097/MD.0000000000030079
work_keys_str_mv AT lixiaoling abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT gaoruixue abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT zhangqinhong abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT liang abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT cailina abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT zhaoweiwei abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT gaoshenglan abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT wangyang abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT yuejinhuan abibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT lixiaoling bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT gaoruixue bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT zhangqinhong bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT liang bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT cailina bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT zhaoweiwei bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT gaoshenglan bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT wangyang bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience
AT yuejinhuan bibliometricanalysisofneuroimagingbiomarkersinparkinsondiseasebasedonwebofscience